These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33368615)

  • 1. Covid Proof Self-Management Training for Caregivers of Patients with Parkinson's Disease.
    Duits AA; Boots LMM; Mulders AEP; Moonen AJH; Vugt ME
    Mov Disord; 2021 Mar; 36(3):529-530. PubMed ID: 33368615
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of home confinement during COVID-19 pandemic on Parkinson's disease.
    Kumar N; Gupta R; Kumar H; Mehta S; Rajan R; Kumar D; Kandadai RM; Desai S; Wadia P; Basu P; Mondal B; Sanchita ; Rawat A; Meka SS; Mishal B; Prashanth LK; Srivastava AK; Goyal V
    Parkinsonism Relat Disord; 2020 Nov; 80():32-34. PubMed ID: 32937224
    [No Abstract]   [Full Text] [Related]  

  • 3. Covid-19 and Parkinson's disease: an overview.
    Cartella SM; Terranova C; Rizzo V; Quartarone A; Girlanda P
    J Neurol; 2021 Dec; 268(12):4415-4421. PubMed ID: 34313818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An educational case series of Parkinson's disease during the COVID-19 pandemic.
    Lo Monaco MR; Colacicco G; Marotta J; Bentivoglio AR;
    Rev Neurol (Paris); 2021; 177(1-2):134-136. PubMed ID: 32951860
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to: "Parkinson's Disease and COVID-19: Do We Need to Be More Patient?".
    Outeiro TF; Krisko A
    Mov Disord; 2021 Feb; 36(2):278-279. PubMed ID: 33599004
    [No Abstract]   [Full Text] [Related]  

  • 6. Parkinson's Disease and COVID-19: Do We Need to Be More Patient?
    Gonzalez-Latapi P; Fearon C; Fasano A; Lang AE
    Mov Disord; 2021 Feb; 36(2):277. PubMed ID: 33599003
    [No Abstract]   [Full Text] [Related]  

  • 7. Self-management support programs for persons with Parkinson's disease: An integrative review.
    Kessler D; Liddy C
    Patient Educ Couns; 2017 Oct; 100(10):1787-1795. PubMed ID: 28465112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience during COVID-19 lockdown and self-managing strategies among caregivers of children with epilepsy: A study from low middle income country.
    Wanigasinghe J; Jayawickrama A; Hewawitharana G; Munasinghe J; Weeraratne CT; Ratnayake P; Wijesekara DS; Fernando S; Rupasinghe P
    Seizure; 2021 Jan; 84():112-115. PubMed ID: 33321430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 in Parkinson's disease: Report on prevalence and outcome.
    Artusi CA; Romagnolo A; Imbalzano G; Marchet A; Zibetti M; Rizzone MG; Lopiano L
    Parkinsonism Relat Disord; 2020 Nov; 80():7-9. PubMed ID: 32920322
    [No Abstract]   [Full Text] [Related]  

  • 10. Implementation of Telemedicine for Urgent and Ongoing Healthcare for Patients with Parkinson's Disease During the COVID-19 Pandemic: New Expectations for the Future.
    Cubo E; Hassan A; Bloem BR; Mari Z;
    J Parkinsons Dis; 2020; 10(3):911-913. PubMed ID: 32417800
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence of Anxiety in Parkinson's Disease During the Coronavirus Disease (COVID-19) Pandemic.
    Salari M; Zali A; Ashrafi F; Etemadifar M; Sharma S; Hajizadeh N; Ashourizadeh H
    Mov Disord; 2020 Jul; 35(7):1095-1096. PubMed ID: 32395849
    [No Abstract]   [Full Text] [Related]  

  • 12. Is COVID-19 a Perfect Storm for Parkinson's Disease?
    Brundin P; Nath A; Beckham JD
    Trends Neurosci; 2020 Dec; 43(12):931-933. PubMed ID: 33158605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardized 25-Hydroxyvitamin D Measurements in Parkinson's Disease Patients With COVID-19.
    Speeckaert MM; Speeckaert R; Delanghe JR
    Mov Disord; 2020 Sep; 35(9):1497. PubMed ID: 33400280
    [No Abstract]   [Full Text] [Related]  

  • 14. Favourable course in a cohort of Parkinson's disease patients infected by SARS-CoV-2: a single-centre experience.
    Buccafusca M; Micali C; Autunno M; Versace AG; Nunnari G; Musumeci O
    Neurol Sci; 2021 Mar; 42(3):811-816. PubMed ID: 33439387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reply to: Standardized 25-Hydroxyvitamin D Measurements in Parkinson's Disease Patients With COVID-19.
    Cereda E; Fasano A; Pezzoli G
    Mov Disord; 2020 Sep; 35(9):1498. PubMed ID: 33400277
    [No Abstract]   [Full Text] [Related]  

  • 16. Telemedicine in Parkinson's Disease: How to Ensure Patient Needs and Continuity of Care at the Time of COVID-19 Pandemic.
    Miele G; Straccia G; Moccia M; Leocani L; Tedeschi G; Bonavita S; Lavorgna L;
    Telemed J E Health; 2020 Dec; 26(12):1533-1536. PubMed ID: 32667839
    [No Abstract]   [Full Text] [Related]  

  • 17. What can Parkinson's disease teach us about COVID-19?
    Tipton PW; Wszolek ZK
    Neurol Neurochir Pol; 2020; 54(2):204-206. PubMed ID: 32323862
    [No Abstract]   [Full Text] [Related]  

  • 18. Parkinson's disease following COVID-19: causal link or chance occurrence?
    Li WS; Chan LL; Chao YX; Tan EK
    J Transl Med; 2020 Dec; 18(1):493. PubMed ID: 33375935
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of probable Parkinson's disease after SARS-CoV-2 infection.
    Cohen ME; Eichel R; Steiner-Birmanns B; Janah A; Ioshpa M; Bar-Shalom R; Paul JJ; Gaber H; Skrahina V; Bornstein NM; Yahalom G
    Lancet Neurol; 2020 Oct; 19(10):804-805. PubMed ID: 32949534
    [No Abstract]   [Full Text] [Related]  

  • 20. Behind the Mask: Recognizing Facial Features of Parkinson's Disease During the COVID-19 Pandemic.
    Soares C; Carneiro DR; Dias R; Ferreira D; Sousa M; Oliveira A; Massano J; Morgadinho A; Rosas MJ; Araújo R
    Mov Disord; 2021 Jun; 36(6):1285-1286. PubMed ID: 33834516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.